New

North America Leukapheresis Market

2021

North America Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025789 | No. of Pages: 118 | Category: Pharmaceuticals | Status: Published

Market Insights

North America Leukapheresis Market to Grow at a CAGR of 9.1% to reach US$ 52.65 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The leukapheresis market in North America is expected to grow from US$ 28.54 million in 2021 to US$ 52.65 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028.

Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. In the US, the estimated number of people living with leukemia or are in remission from leukemia totals ~376,508. Leukemia was the sixth most common cause of cancer-related deaths in both men and women in the US during 2012–2016. In 2020, ~23,100 people are expected to die from leukemia (13,420 males and 9,680 females). Further, according to the National Heart, Lung, and Blood Institute, anemia affects more than 3 million Americans every year, while as per the WHO, it affects ~1.62 billion people worldwide. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.

North America has been witnessing a growing number of COVID-19 cases since its outbreak. The cases are also increasing in Mexico. In Mexico. At present, the majority of the diagnostic laboratories and research institutes are engaged in diagnosing the COVID-19 patients. Currently, the COVID-19 diagnostic testing industry is witnessing upsurge on account of a growing number of cases coupled with the increasing emergency use authorizations from the regulatory bodies. In addition, With the WHO declaring the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies and small startups have stepped forward to develop treatments that target the infection. The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The FDA issued this emergency use authorization to Terumo BCT Inc. and Marker Therapeutics AG for their Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America leukapheresis market. The North America leukapheresis market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :


North America Leukapheresis Market Segmentation

North America Leukapheresis Market – By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

North America Leukapheresis Market – By Application

  • Research Applications
  • Therapeutic Applications

North America Leukapheresis Market – By Product Type

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

North America Leukapheresis Market – By Country

  • US
  • Canada
  • Mexico

North America Leukapheresis Market – Companies Mentioned

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Leukapheresis Market – By Product Type

1.3.2 North America Leukapheresis Market – By Application

1.3.3 North America Leukapheresis Market – By End User

1.3.4 North America Leukapheresis Market – By Country

2. North America Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Leukapheresis Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. North America Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Number of Voluntary Blood Donors

5.1.2 Raising Incidence of Hematologic Diseases

5.1.3 Up-lifting Elderly Population

5.2 Key Market Restraints

5.2.1 High Price of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Growing Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Progress in Therapeutic Apheresis

5.5 Impact Analysis

6. North America Leukapheresis – Market Analysis

6.1 North America Leukapheresis Market Revenue Forecast and Analysis

7. North America Leukapheresis Market Analysis – by Product Type

7.1 Overview

7.2 North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8. North America Leukapheresis Market Analysis – by Application

8.1 Overview

8.2 North America Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9. North America Leukapheresis Market Analysis – by End User

9.1 Overview

9.2 North America Leukapheresis Market Share by End User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10. North American Leukapheresis Market – Country Analysis

10.1 Overview

10.1.1 North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.1.1.3.1 US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4 US: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5 US: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.1.2.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.4 Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.5 Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)

10.1.1.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4 Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5 Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11. North America Leukapheresis Market – Impact of COVID-19 Pandemic

11.1 Impact Assessment of COVID-19 Pandemic

12. Leukapheresis Market– Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done by Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1. North America Leukapheresis Market Segmentation

Figure 2. North America Leukapheresis Market Segmentation, By country

Figure 3. North America Leukapheresis Market Overview

Figure 4. North America Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America Leukapheresis Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Leukapheresis market impact analysis of driver and restraints

Figure 9. North America Leukapheresis Market – Revenue Forecast and Analysis (2021-2028)

Figure 10. North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. North America Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. North America Leukapheresis Market Share by End User 2021 & 2028 (%)

Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. North America: Leukapheresis Market, by Key Country – Revenue (2021 USD Million)

Figure 25. North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26. US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Impact of COVID-19 Pandemic in North American Country Markets

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT 
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025789
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.